<i>Lactobacillus delbrueckii</i> subsp. <i>bulgaricus</i> 1.0207 Exopolysaccharides Attenuate Hydrogen Peroxide-Induced Oxidative Stress Damage in IPEC-J2 Cells through the Keap1/Nrf2 Pathway
<i>Lactobacillus delbrueckii</i> subsp. <i>bulgaricus</i> (<i>L. bulgaricus</i>) is one of the most commonly employed <i>Lactobacillus</i> in the food industry. Exopolysaccharides (EPS) of <i>Lactobacillus</i>, which are known to exhibit pr...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_dc1b1701d0614b868a5b766c7d6e5abf | ||
042 | |a dc | ||
100 | 1 | 0 | |a Deyu Liu |e author |
700 | 1 | 0 | |a Yingxue Yue |e author |
700 | 1 | 0 | |a Lijun Ping |e author |
700 | 1 | 0 | |a Cuicui Sun |e author |
700 | 1 | 0 | |a Tingting Zheng |e author |
700 | 1 | 0 | |a Yang Cheng |e author |
700 | 1 | 0 | |a Guicheng Huo |e author |
700 | 1 | 0 | |a Bailiang Li |e author |
245 | 0 | 0 | |a <i>Lactobacillus delbrueckii</i> subsp. <i>bulgaricus</i> 1.0207 Exopolysaccharides Attenuate Hydrogen Peroxide-Induced Oxidative Stress Damage in IPEC-J2 Cells through the Keap1/Nrf2 Pathway |
260 | |b MDPI AG, |c 2024-09-01T00:00:00Z. | ||
500 | |a 10.3390/antiox13091150 | ||
500 | |a 2076-3921 | ||
520 | |a <i>Lactobacillus delbrueckii</i> subsp. <i>bulgaricus</i> (<i>L. bulgaricus</i>) is one of the most commonly employed <i>Lactobacillus</i> in the food industry. Exopolysaccharides (EPS) of <i>Lactobacillus</i>, which are known to exhibit probiotic properties, are secondary metabolites produced during the growth of <i>Lactobacillus</i>. This study identified the structure of the EPS produced by <i>L. bulgaricus</i> 1.0207 and investigated the mitigation of <i>L. bulgaricus</i> 1.0207 EPS on H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in IPEC-J2 cells. <i>L. bulgaricus</i> 1.0207 EPS consisted of glucose and galactose and possessed a molecular weight of 4.06 × 10<sup>4</sup> Da. <i>L. bulgaricus</i> 1.0207 EPS exhibited notable scavenging capacity against DPPH, hydroxyl radicals, superoxide anions, and ABTS radicals. Additionally, <i>L. bulgaricus</i> 1.0207 EPS enhanced cell proliferation, reduced intracellular reactive oxygen species (ROS) accumulation, increased activity of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT), and total antioxidant capacity (T-AOC) elevated the relative expression of CAT, SOD, HO-1, NQO1, ZO-1, and Occludin genes. Moreover, <i>L. bulgaricus</i> 1.0207 EPS improved the expression of Nrf2, <i>p</i>Nrf2, <i>p</i>Nrf2/Nrf2, and Bcl-2 proteins, while decreasing the expression of Keap1, Caspase3, and Bax proteins, with the best effect at a concentration of 100 μg/mL. <i>L. bulgaricus</i> 1.0207 EPS mitigated H<sub>2</sub>O<sub>2</sub>-induced oxidative stress injury in IPEC-J2 cells by activating the Keap1/Nrf2 pathway. Meanwhile, <i>L. bulgaricus</i> 1.0207 EPS exhibited the potential to decrease apoptosis and restore the integrity of the gut barrier. The findings establish a theoretical foundation for the development and application of <i>L.bulgaricus</i> 1.0207 and its EPS. | ||
546 | |a EN | ||
690 | |a <i>Lactobacillus bulgaricus</i> | ||
690 | |a exopolysaccharides | ||
690 | |a oxidative stress | ||
690 | |a IPEC-J2 cells | ||
690 | |a Keap1/Nrf2 pathway | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antioxidants, Vol 13, Iss 9, p 1150 (2024) | |
787 | 0 | |n https://www.mdpi.com/2076-3921/13/9/1150 | |
787 | 0 | |n https://doaj.org/toc/2076-3921 | |
856 | 4 | 1 | |u https://doaj.org/article/dc1b1701d0614b868a5b766c7d6e5abf |z Connect to this object online. |